Embedded Files
These are first and corresponding authors who are listed on 한빛사 (한국을 빛내는 사람들, People Who Made Korea Shine) by BRIC for their publications on high impact journals and of high citations.
These are first and corresponding authors who are listed on 한빛사 (한국을 빛내는 사람들, People Who Made Korea Shine) by BRIC for their publications on high impact journals and of high citations.
2024
2024
2023
2023
2023
Accounts of Chemical Research. 2024;57(22):3266. Chemical-driven amyloid clearance for therapeutics and diagnostics of Alzheimer’s disease. Kim H, Kim Y*. link Cover
Angewandte Chemie International Edition. 2024. ePub ahead. Drug discovery and screening tool development for tauopathies by focusing on pathogenic tau repeat 3 oligomers. Yoon S, Kim HY, Park S, Cha M, Kim K, Lee S, Kim JM, Bhang S, Kim Y*. link Interview Webinar
Nature Communications. 2024;15:1004. Early onset diagnosis in Alzheimer’s disease patients via amyloid-β oligomers-sensing probe in cerebrospinal fluid. link
Angewandte Chemie International Edition. 2023;62(7):e202210209. Amyloid against amyloid: dimeric amyloid fragment ameliorates cognitive impairments by direct clearance of oligomers and plaques. link
Advanced Materials. 2023;35(3):2207719. A therapeutic nanovaccine that generates anti-amyloid antibodies and amyloid-specific regulatory T cells for Alzheimer's disease. link
Advanced Science. 2022;9(12):e2104542. Chemical-driven outflow of dissociated amyloid burden from brain to blood. link Interview
Angewandte Chemie International Edition. 2020;59(51):22994. Rhizolutin, a novel 7/10/6‐tricyclic dilactone, dissociates misfolded protein aggregates and reduces apoptosis/inflammation associated with Alzheimer’s disease. link Interview
Angewandte Chemie International Edition. 2020;59(28):11491 . Discovery of chemicals to either clear or indicate amyloid aggregates by targeting memory‐impairing anti‐parallel Aβ dimers. link Interview Webinar
Experimental & Molecular Medicine. 2019;51:53. Diagnosis of Alzheimer’s disease utilizing amyloid and tau as fluid biomarkers. link
ACS Central Science. 2019;5(2):209. Frontiers in probing Alzheimer’s disease biomarkers with fluorescent small molecules. link
Science Advances. 2019;5(4):eaav1388. Comparative analyses of plasma amyloid-β levels in heterogeneous and monomerized states by interdigitated microelectrode sensor system. link Interview
EMBO Molecular Medicine. 2017;9:61. Nec-1 alleviates cognitive impairment with reduction of Aβ and tau abnormalities in APP/PS1 mice. link
Journal of Visualized Experiments. 2016;109:e53308. Intracerebroventricular injection of amyloid-β peptides in normal mice to acutely induce Alzheimer-like cognitive deficits. link
Nature Communications. 2015;6:8997. EPPS rescues hippocampus-dependent cognitive deficits in APP/PS1 mice by disaggregation of amyloid-β oligomers and plaques. link Interview Webinar
Scientific Reports. 2014;4:7467. Taurine in drinking water recovers learning and memory in the adult APP/PS1 mouse model of Alzheimer's disease. link
Amyloid. 2013;20(1):7-12. Amelioration of Alzheimer's disease by neuroprotective effect of sulforaphane in animal model. link
Biochemistry. 2006;45(31):9434-44. Targeting heat shock proteins on cancer cells: selection, characterization, and cell-penetrating properties of a peptidic GRP78 ligand. link
Article Cakes
Page updated
Report abuse